Steven H. Bernstein, M.D.

Steven H. Bernstein, M.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Fax: (585) 273-1042
Administrative: (585) 275-4099

Professional Bio

Steven H. Bernstein, MD, is Professor of Medicine and Co-Director of the
Lymphoma Biology Program at the James P. Wilmot Cancer Center, University of Rochester Medical Center, New York, NY. He earned a medical degree from the New York University School of Medicine. Subsequently, he was a clinical fellow in hematology and oncology at Beth Israel Hospital in Boston, Massachusetts, and a research fellow in medicine in the Laboratory of Clinical Pharmacology at Dana-Farber Cancer Institute in Boston.

Dr. Bernstein is a member of the American Society of Clinical Oncology, American Society for Blood and Marrow Transplantation, American Association for Cancer Research, American Society of Hematology, and American College of Physicians. Dr. Bernstein is also a member of the Lymphoma Working Group, Lymphoma Core Committee, and Lymphoma Biology Committee of the Southwest Oncology Group (SWOG). He has published numerous articles in peer-reviewed journals and has
authored numerous abstracts and four book chapters. Dr. Bernstein has been awarded numerous grants to study hematologic malignancies and has been the principal investigator for many clinical protocols in lymphomas and leukemias.

Awards & Honors (Local)

American Cancer Society Clinical Oncology Career Development Award 1992
Burroughs Wellcome Fund Supplemental Stipend Award 1990
American Cancer Society Physicians Research Training Grant 1987
Phi Beta Kappa 1980
B.A. Degree, Magna Cum Laude 1980

Recent Journal Articles

Showing the 5 most recent journal articles. 46 available »

2014 Jan 1
Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos I, Agarwal AB, Jung J, Burack R, Zhou X, Leonard EJ, Fingert H, Danaee H, Bernstein SH. "Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 Jan 1; 32(1):44-50. Epub 2013 Sep 16.
2013 Oct
Solh M, Fisher RI, Goy A, de Vos S, Bernstein SH, Esseltine DL, Neuwirth R, Morrison VA. "Herpes zoster complicating bortezomib therapy of relapsed/refractory indolent B-cell and mantle cell lymphoma: an analysis of two phase II trials." Leukemia & lymphoma.. 2013 Oct; 54(10):2185-9. Epub 2013 Mar 08.
2013 Sep
Williams ME, Bernstein SH, Jares P, Kahl BS, Witzig TE, Gordon LI. "Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop." Leukemia & lymphoma.. 2013 Sep; 54(9):1882-90. Epub 2013 Mar 04.
2013 Feb
Longhi MS, Robson SC, Bernstein SH, Serra S, Deaglio S. "Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states." Journal of molecular medicine (Berlin, Germany). 2013 Feb; 91(2):165-72. Epub 2013 Jan 06.
2012 Apr 5
Bernstein SH, Venkatesh S, Li M, Lee J, Lu B, Hilchey SP, Morse KM, Metcalfe HM, Skalska J, Andreeff M, Brookes PS, Suzuki CK. "The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives." Blood.. 2012 Apr 5; 119(14):3321-9. Epub 2012 Feb 08.


Hematology and Oncology - American Board of Internal Medicine
Internal Medicine - American Board of Internal Medicine


MD | Medicine | New York Univ Sch Medicine1984
BA | Arts & Sciences | Brandeis University1980

Post-Doctoral Training & Residency

Research Fellow in Medicine Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute. Boston, MA 1990
Clinical Fellow in Hematology and Medical Oncology, Beth Israel Hospital. Boston, MA 1991
Resident, Department of Medicine, New York University Medical Center/Bellevue Hospital. New York, NY 1987
Intern, Department of Medicine, University of Chicago Hospitals and Clinics. Chicago, IL 1985